Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axisYuanyuan Zeng, Zeyi Liu, Anqi Wang et al.|npj Precision Oncology|2024Cited by 6
Liensinine overcomes EGFR-TKI resistance in lung adenocarcinoma through DRP1-mediated autophagyYuling Chen, Zeyi Liu, Chenying Shu et al.|Phytomedicine|2025Cited by 4